| 12338233 |
PD-1/Pd-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2025-06-24 |
|
| 12269812 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2025-04-08 |
|
| 12139474 |
LPA receptor antagonists and uses thereof |
Doris T. Tang, Chandrasekar Venkataramani, Kin S. Yang, Anna Zagorska |
2024-11-12 |
$714,990,000 |
| 11999717 |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Zhimin Du, Julie Farand, Gregory Notte, Doris T. Tang +4 more |
2024-06-04 |
$207,190,000 |
| 11939318 |
LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Joshua A. Kaplan, Kin S. Yang, Anna Zagorska |
2024-03-26 |
$240,166,000 |
| 11702407 |
LPA receptor antagonists and uses thereof |
Doris T. Tang, Chandrasekar Venkataramani, Kin S. Yang, Anna Zagorska |
2023-07-18 |
$149,671,000 |
| 11584738 |
LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Zhimin Du, Julie Farand, Joshua A. Kaplan, Doris T. Tang +4 more |
2023-02-21 |
$220,051,000 |
| 11555029 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2023-01-17 |
$669,972,000 |
| 11548871 |
Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof |
Brian P. Bestvater, Zhimin Du, Julie Farand, Gregory Notte, Doris T. Tang +4 more |
2023-01-10 |
$214,003,000 |
| 11236085 |
PD-1/PD-L1 inhibitors |
Zhimin Du, Michael Graupe, Paulo A. Machicao Tello, Jonathan William Medley, Samuel E. Metobo +5 more |
2022-02-01 |
$369,757,000 |
| 11021467 |
Phosphatidylinositol 3-kinase inhibitors |
Shaopei Cai, Zhimin Du, Musong Kim, Jennifer A. Loyer-Drew, Devan Naduthambi +7 more |
2021-06-01 |
$494,660,000 |
| 10899735 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2021-01-26 |
$775,784,000 |
| 10774071 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more |
2020-09-15 |
$253,208,000 |
| 10710986 |
PD-1/PD-L1 inhibitors |
Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more |
2020-07-14 |
$847,542,000 |
| 10603318 |
Inhibitors of hepatitis C virus |
Eda Canales, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana, Darryl Kato +15 more |
2020-03-31 |
|
| 10335409 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Eda Canales, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana +15 more |
2019-07-02 |
|
| 10316049 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, David Dornan, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox +5 more |
2019-06-11 |
$144,231,000 |
| 10308639 |
Phosphatidylinositol 3-kinase inhibitors |
Jerry Evarts, Joshua A. Kaplan, Leena Patel, Stephane Perreault, Gary Phillips +2 more |
2019-06-04 |
$121,883,000 |
| 10259811 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Devan Naduthambi +4 more |
2019-04-16 |
$383,951,000 |
| 10253019 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Jennifer R. Lo +6 more |
2019-04-09 |
$137,397,000 |
| 10221197 |
Phosphatidylinositol 3-kinase inhibitors |
Zhimin Du, Jerry Evarts, Joshua A. Kaplan, Musong Kim, Devan Naduthambi +8 more |
2019-03-05 |
$131,246,000 |
| 10092563 |
Phosphatidylinositol 3-kinase inhibitors |
Shaopei Cai, Zhimin Du, Joshua A. Kaplan, Jennifer A. Loyer-Drew, Devan Naduthambi +4 more |
2018-10-09 |
$485,739,000 |
| 10072001 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Devan Naduthambi +4 more |
2018-09-11 |
$246,857,000 |
| 10040781 |
Tank-binding kinase inhibitor compounds |
Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Jennifer R. Lo +6 more |
2018-08-07 |
$258,623,000 |
| 9655944 |
Inhibitors of hepatitis C virus |
Kyla Bjornson, Eda Canales, Jeromy J. Cottell, Kapil Kumar Karki, Ashley Anne Katana +15 more |
2017-05-23 |
$417,828,000 |